The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials

Figure 10

The analysis of publication bias.

(a) ORR

(b) DCR

(c) CD3⁺ T cells

(d) CD3⁺ CD4⁺ T cell

(e) CD3⁺ CD8⁺ T cells

(f) CD4⁺/CD8⁺ T cell ratio

(g) NK cells